CONTENTS xxi 



SUB-DIVISION VI. THE SPORE-BEARING, GRAM-POSITIVE, 

 AEROBIC BACILLI. 



XXXV. Bacillus anthracis. 



Introduction, - - 517 



Section I. The experimental disease, 518 



(1) Susceptible and immune animals, p. 518. (2) Methods of inocula- 

 tion, p. 519. (3) Symptoms and lesions in experimental animals, 

 p. 519. 



Section II. Morphology, - 520 



(1) Microscopical appearance and staining reactions, p. 520. (2) 

 Cultural characteristics, p. 524. 



Section III. Biological properties, - 525 



(1) Viability and resistance, p. 525. (2) Virulence, p. 527. (3) 

 Toxin, p. 529. (4) Serum therapy, p. 530. (5) Agglutination, 

 p. 533. 



Section I V. Detection, isolation and identification of the anthrax 



bacillus, - - 533 



Examination of carcases dead of anthrax, p. 534. Isolation of the 

 bacillus from soil, 535. 



SUB-DIVISION VII. THE SPORE-BEARING, GRAM-POSITIVE, 

 ANAEROBIC BACILLI. 



XXXVI. Bacillus tetani. 



Introduction, - - 536 



Section I. Experimental inoculation, - 536 



(1) Inoculation of soil or pus, p. 537. (2) Inoculation of pure cul- 

 tures, p. 537. (3) Inoculation of spores, p. 538. 



Section II. Morphology, 539 



Section III. Biological properties, - 541 



(1) Vitality and virulence, p. 541. (2) Toxin, p. 541. (3) Vaccina- 

 tion, p. 544. (4) Serum therapy, p. 545. (5) Agglutination, p. 548. 



Section IV. Detection, isolation and identification of the tetanus 



bacillus, - - 548 



Bacillus botulinus, p. 549. 



XXXVII. The bacillus of quarter ill. 



Introduction, - -.-.- 552 



Section I. The experimental disease, - - 552 



Section 11. Morphology, ~ 554 



Section III. Biological properties, - 556 



(1) Vitality and virulence, p. 556. (2) Vaccination, p. 556. (3) 

 Toxin, p. 558. (4) Serum therapy, p. 559. (5) Agglutination, p. 560. 



